89 related articles for article (PubMed ID: 16469420)
1. Peptide-binding assays and HLA II transgenic Abeta degrees mice are consistent and complementary tools for identifying HLA II-restricted peptides.
Depil S; Angyalosi G; Moralès O; Delacre M; Delhem N; François V; Georges B; Hammer J; Maillère B; Auriault C; Pancré V
Vaccine; 2006 Mar; 24(13):2225-9. PubMed ID: 16469420
[TBL] [Abstract][Full Text] [Related]
2. Human immunodeficiency virus type 1 Nef epitopes recognized in HLA-A2 transgenic mice in response to DNA and peptide immunization.
Sandberg JK; Leandersson AC; Devito C; Kohleisen B; Erfle V; Achour A; Levi M; Schwartz S; Kärre K; Wahren B; Hinkula J
Virology; 2000 Jul; 273(1):112-9. PubMed ID: 10891413
[TBL] [Abstract][Full Text] [Related]
3. Identification of T cell determinants on human type II collagen recognized by HLA-DQ8 and HLA-DQ6 transgenic mice.
Krco CJ; Watanabe S; Harders J; Griffths MM; Luthra H; David CS
J Immunol; 1999 Aug; 163(3):1661-5. PubMed ID: 10415072
[TBL] [Abstract][Full Text] [Related]
4. Induction of arthritis in HLA-DR4-humanized and HLA-DQ8-humanized mice by human cartilage proteoglycan aggrecan but only in the presence of an appropriate (non-MHC) genetic background.
Szántó S; Bárdos T; Szabó Z; David CS; Buzás EI; Mikecz K; Glant TT
Arthritis Rheum; 2004 Jun; 50(6):1984-95. PubMed ID: 15188376
[TBL] [Abstract][Full Text] [Related]
5. Novel promiscuous HLA-DQ HIV Nef peptide that induces IFN-gamma-producing memory CD4+ T cells.
Pancré V; Georges B; Angyalosi G; Castelli F; Delanoye A; Delacre M; Hachulla E; Maillere B; Bouzidi A; Auriault C
Clin Exp Immunol; 2002 Sep; 129(3):429-37. PubMed ID: 12197883
[TBL] [Abstract][Full Text] [Related]
6. Use of complete eluted peptide sequence data from HLA-DR and -DQ molecules to predict T cell epitopes, and the influence of the nonbinding terminal regions of ligands in epitope selection.
Godkin AJ; Davenport MP; Willis A; Jewell DP; Hill AV
J Immunol; 1998 Jul; 161(2):850-8. PubMed ID: 9670963
[TBL] [Abstract][Full Text] [Related]
7. Induction of EBV-latent membrane protein 1-specific MHC class II-restricted T-cell responses against natural killer lymphoma cells.
Kobayashi H; Nagato T; Takahara M; Sato K; Kimura S; Aoki N; Azumi M; Tateno M; Harabuchi Y; Celis E
Cancer Res; 2008 Feb; 68(3):901-8. PubMed ID: 18245493
[TBL] [Abstract][Full Text] [Related]
8. Identification of HLA-DRB1*1501-restricted T-cell epitopes from human prostatic acid phosphatase.
Klyushnenkova EN; Kouiavskaia DV; Kodak JA; Vandenbark AA; Alexander RB
Prostate; 2007 Jul; 67(10):1019-28. PubMed ID: 17455230
[TBL] [Abstract][Full Text] [Related]
9. HLA class II transgenic mice mimic human inflammatory diseases.
Mangalam AK; Rajagopalan G; Taneja V; David CS
Adv Immunol; 2008; 97():65-147. PubMed ID: 18501769
[TBL] [Abstract][Full Text] [Related]
10. Comparison of HLA-DR1-restricted T cell response induced in HLA-DR1 transgenic mice deficient for murine MHC class II and HLA-DR1 transgenic mice expressing endogenous murine MHC class II molecules.
Pajot A; Pancré V; Fazilleau N; Michel ML; Angyalosi G; Ojcius DM; Auriault C; Lemonnier FA; Lone YC
Int Immunol; 2004 Sep; 16(9):1275-82. PubMed ID: 15249541
[TBL] [Abstract][Full Text] [Related]
11. A novel strategy for the discovery of MHC class II-restricted tumor antigens: identification of a melanotransferrin helper T-cell epitope.
Röhn TA; Reitz A; Paschen A; Nguyen XD; Schadendorf D; Vogt AB; Kropshofer H
Cancer Res; 2005 Nov; 65(21):10068-78. PubMed ID: 16267033
[TBL] [Abstract][Full Text] [Related]
12. Prediction of peptide affinity to HLA DRB1*0401.
Marshall KW; Wilson KJ; Liang J; Woods A; Zaller D; Rothbard JB
J Immunol; 1995 Jun; 154(11):5927-33. PubMed ID: 7751636
[TBL] [Abstract][Full Text] [Related]
13. [Induction of neutralizing antibodies against HIV-1 viruses in HLA-DQ6 mice by peptide vaccines].
Takahashi A
Hokkaido Igaku Zasshi; 1998 Mar; 73(2):147-56. PubMed ID: 9612708
[TBL] [Abstract][Full Text] [Related]
14. Differential capacity of T cell priming in naive donors of promiscuous CD4+ T cell epitopes of HCV NS3 and Core proteins.
Castelli FA; Leleu M; Pouvelle-Moratille S; Farci S; Zarour HM; Andrieu M; Auriault C; Ménez A; Georges B; Maillere B
Eur J Immunol; 2007 Jun; 37(6):1513-23. PubMed ID: 17492804
[TBL] [Abstract][Full Text] [Related]
15. The Th1 immune response against HIV-1 Gag p24-derived peptides in mice expressing HLA-A02.01 and HLA-DR1.
Pajot A; Schnuriger A; Moris A; Rodallec A; Ojcius DM; Autran B; Lemonnier FA; Lone YC
Eur J Immunol; 2007 Sep; 37(9):2635-44. PubMed ID: 17668896
[TBL] [Abstract][Full Text] [Related]
16. Identification of a promiscuous HLA DR-restricted T-cell epitope derived from the inhibitor of apoptosis protein survivin.
Piesche M; Hildebrandt Y; Zettl F; Chapuy B; Schmitz M; Wulf G; Trümper L; Schroers R
Hum Immunol; 2007 Jul; 68(7):572-6. PubMed ID: 17584578
[TBL] [Abstract][Full Text] [Related]
17. Resistance to celiac disease in humanized HLA-DR3-DQ2-transgenic mice expressing specific anti-gliadin CD4+ T cells.
de Kauwe AL; Chen Z; Anderson RP; Keech CL; Price JD; Wijburg O; Jackson DC; Ladhams J; Allison J; McCluskey J
J Immunol; 2009 Jun; 182(12):7440-50. PubMed ID: 19494267
[TBL] [Abstract][Full Text] [Related]
18. HLA-DR alleles in amyloid beta-peptide autoimmunity: a highly immunogenic role for the DRB1*1501 allele.
Zota V; Nemirovsky A; Baron R; Fisher Y; Selkoe DJ; Altmann DM; Weiner HL; Monsonego A
J Immunol; 2009 Sep; 183(5):3522-30. PubMed ID: 19675171
[TBL] [Abstract][Full Text] [Related]
19. Role of MHC class II expressing CD4+ T cells in proteolipid protein(91-110)-induced EAE in HLA-DR3 transgenic mice.
Mangalam A; Rodriguez M; David C
Eur J Immunol; 2006 Dec; 36(12):3356-70. PubMed ID: 17125142
[TBL] [Abstract][Full Text] [Related]
20. HLA and leprosy in the pre and postgenomic eras.
Geluk A; Ottenhoff TH
Hum Immunol; 2006 Jun; 67(6):439-45. PubMed ID: 16728267
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
